Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9083)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 28, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ohkoshi S, Hirono H, Watanabe K, Hasegawa K, Kamimura K, Yano M. Natural regression of fibrosis in chronic hepatitis B. World J Gastroenterol 2016; 22(24): 5459-5466 [PMID: 27350724 DOI: 10.3748/wjg.v22.i24.5459] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i24/5459.htm |
| Number | Citing Articles |
| 1 |
Zhan-qing Zhang, Bi-sheng Shi, Wei Lu, Dan-ping Liu, Dan Huang, Yan-ling Feng. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients. Gastroenterología y Hepatología (English Edition) 2020; 43(9): 526 doi: 10.1016/j.gastre.2020.03.005
|
| 2 |
Yi-Ning Dai, Yue-Xing Tu, Di Meng, Mei-Juan Chen, Jia-Jie Zhang, Yu-Han Gong, Yong-Xi Tong, Ming-Shan Wang, Hong-Ying Pan, Hai-Jun Huang. Serum Proteomic Changes as Candidate Biomarkers of Intermediate Liver Fibrosis in Chronic Hepatitis B Infection. OMICS: A Journal of Integrative Biology 2019; 23(3): 167 doi: 10.1089/omi.2018.0179
|
| 3 |
D. Liu, J. Li, W. Lu, Y. Wang, X. Zhou, D. Huang, X. Li, R. Ding, Z. Zhang. Gamma-glutamyl transpeptidase to cholinesterase and platelet ratio in predicting significant liver fibrosis and cirrhosis of chronic hepatitis B. Clinical Microbiology and Infection 2019; 25(4): 514.e1 doi: 10.1016/j.cmi.2018.06.002
|
| 4 |
Ya-Xin Huang, Qi-Yi Zhao, Li-Li Wu, Dong-Ying Xie, Zhi-Liang Gao, Hong Deng. Increased CCR7loPD-1hiCXCR5+CD4+ T Cells in Peripheral Blood Mononuclear Cells Are Correlated with Immune Activation in Patients with Chronic HBV Infection. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/1020925
|
| 5 |
Zhan-qing Zhang, Bi-sheng Shi, Wei Lu, Dan-ping Liu, Dan Huang, Yan-ling Feng. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients. Gastroenterología y Hepatología 2020; 43(9): 526 doi: 10.1016/j.gastrohep.2020.03.017
|
| 6 |
ByukGyung Choi, In Young Choi, Sang Hoon Cha, Suk Keu Yeom, Hwan Hoon Chung, Seung Hwa Lee, Jaehyung Cha, Ju-Han Lee. Feasibility of computed tomography texture analysis of hepatic fibrosis using dual-energy spectral detector computed tomography. Japanese Journal of Radiology 2020; 38(12): 1179 doi: 10.1007/s11604-020-01020-5
|
| 7 |
James M. Crawford, Paulette Bioulac-Sage, Prodromos Hytiroglou. Macsween's Pathology of the Liver. 2018; : 1 doi: 10.1016/B978-0-7020-6697-9.00001-7
|
| 8 |
D.‐P. Liu, W. Lu, Z.‐Q. Zhang, Y.‐B. Wang, R.‐R. Ding, X.‐L. Zhou, D. Huang, X.‐F. Li. Comparative evaluation of GPR versus APRI and FIB‐4 in predicting different levels of liver fibrosis of chronic hepatitis B. Journal of Viral Hepatitis 2018; 25(5): 581 doi: 10.1111/jvh.12842
|
| 9 |
Bicong Wu, Matthew M. Yeh. Hepatitis B Virus and Liver Disease. 2021; : 99 doi: 10.1007/978-981-16-3615-8_5
|
| 10 |
Lanlan Xiao, Jiajia Chen, Shuai Zhao, Wenxin Zhoudi, Keting He, Xiaohan Qian, Fen Zhang, Qiuhong Liu, Tan Li, Danhua Zhu, Xiaoxin Wu, Zhangya Pu, Jianrong Huang, Zhongyang Xie, Xiaowei Xu. The 90‐Day Survival Threshold: A Pivotal Determinant of Long‐Term Prognosis in HBV‐ACLF Patients – Insights from a Prospective Longitudinal Cohort Study. Advanced Science 2024; doi: 10.1002/advs.202304381
|
| 11 |
Driton Vela. Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker. Molecular Medicine 2018; 24(1) doi: 10.1186/s10020-018-0008-7
|
| 12 |
Cheng-Jen Chen, Pei-Kwei Tsay, Shiu-Feng Huang, Po-Hsiang Tsui, Wan-Ting Yu, Tse-Hwa Hsu, Jennifer Tai, Dar-In Tai. Effects of Hepatic Steatosis on Non-Invasive Liver Fibrosis Measurements Between Hepatitis B and Other Etiologies. Applied Sciences 2019; 9(9): 1961 doi: 10.3390/app9091961
|
| 13 |
James M. Crawford, Paulette Bioulac-Sage, Prodromos Hytiroglou. MacSween's Pathology of the Liver. 2024; : 1 doi: 10.1016/B978-0-7020-8228-3.00001-6
|